For pharmaceutical companies and scientific offices

• Registration. Medicines are registered with the federal Ministry of Health through its Directorate of Technical Affairs. A registration is valid for five years for an imported product and ten years for a product made in Iraq.
• Testing. The National Center for Drug Control and Research, founded in 1984, tests products for registration and usually examines batches of imported and Iraqi-made medicines.
• The state buyer. Kimadia, the ministry's state company for marketing drugs and medical appliances, imports and distributes medicines and medical supplies for public health facilities, by tender. Foreign manufacturers take part through a registered Iraqi agent, and Kimadia's practice has tended to favour suppliers with a local representative or a scientific office.
• The private market. Private companies also import and sell medicines. The Ministry of Health issues an import licence for each private-sector consignment once its documents are presented.
• The Kurdistan Region. The Kurdistan Region, Erbil included, has its own Ministry of Health, and a manufacturing site is registered with either the federal ministry or the Kurdistan Medicines Control Agency.

We stand outside this chain. We register no medicines, act as no one's agent, take part in no Kimadia tender and supply nothing for treatment.

Laboratory material for your R&D and quality control. Your laboratories buy research-grade peptides as any other laboratory does. We read your company documents, the head of the laboratory signs an end-use declaration, and the material stays in the laboratory, never used in people or animals. For research laboratories

Cosmetic ingredients for a cosmetics line. If your company also makes cosmetics, it orders cosmetic-grade peptides for that line like any cosmetic manufacturer. Cosmetic-grade peptides

Completed supplier questionnaires. Send your qualification questionnaire with the first enquiry, and we answer it in writing. The batch certificate comes with the goods; a safety data sheet or the manufacturer's specification is sent on request, where the manufacturer issues one. Where we hold no document, we say so.

• Anything for treatment, compounding or dispensing. A research-labelled vial is never sold for any of them, and an order that points that way is declined.
• Medicines and medical supplies. We neither distribute medicines nor trade in medical supplies. Hospitals and pharmacies get registered medicines through Kimadia and the licensed private importers and pharmaceutical distributors.
• Starting material for a registered medicine. A registered medicine must be made from materials that match what its registration dossier specifies. Research-labelled vials are never offered as pharmaceutical raw material.
• Goods for pharmacy or drug store shelves. Their customers are patients, and research-grade products are not sold to them in any quantity.
• Private orders. Individuals are refused, whatever reason they give.

On 6 June 2026 the Kurdistan Region's Ministry of Health reported that its laboratory tests had found a banned substance, sibutramine, in a slimming product, and urged people to stop using products promoted on social media without a licence and ministry approval. In the same year regulators in Saudi Arabia, Jordan and Qatar acted or warned against unlicensed peptides.

A research vial handed to a patient would be an unlicensed product of exactly the sort those warnings concern. We decline to be the source of one.

Some pharmaceutical distributors also serve laboratories or cosmetic manufacturers. For that side of the business a trade account is possible, as long as your company registration covers the goods and every customer is a laboratory or a manufacturer. Distributors and trade accounts